Evidence map›Paper›PMID 29077651›Full record

ArticleThe Journal of nervous and mental disease2017

Exploring the Relationship Between Body Mass Index and Positive Symptom Severity in Persons at Clinical High Risk for Psychosis.

Fernando Caravaggio, Gary Brucato, Lawrence S Kegeles, Eugénie Lehembre-Shiah, Leigh Y Arndt, Tiziano Colibazzi, Ragy Girgis

Open access · greenAbstract read
In one paragraph

Article in The Journal of nervous and mental disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fernando Caravaggio*Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; and †Department of Psychiatry and Radiology, and ‡The Center of Prevention & Evaluation, Columbia University College of Physicians and Surgeons, and the New York State Psychiatric Institute, New York, New York.
Gary Brucato
Lawrence S Kegeles
Eugénie Lehembre-Shiah
Leigh Y Arndt
Tiziano Colibazzi
Ragy Girgis
College of Physicians and Surgeons of Ontario · CA

Funding

Longitudinal Imaging of Patients at Clinical Risk for Psychosis.R01MH093398 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SMALL, SCOTT A · 2011 to 2015
$2.5M
Multimodal MR Imaging of the Glutamate System in SchizophreniaK23MH106746 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI GIRGIS, RAGY RAMSIS · 2015 to 2016
$370k
NIMH NIH HHS K23 MH106746NIMH NIH HHS R01 MH093398
6 · The paper itself

Abstract

Metabolic health and positive symptom severity has been investigated in schizophrenia, but not in clinical high risk (CHR) patients. We hypothesized that greater body mass index (BMI) in CHR patients would be related to less positive symptoms. We examined this relationship in CHR patients being treated with 1) no psychotropic medications (n = 58), 2) an antipsychotic (n = 14), or 3) an antidepressant without an antipsychotic (n = 10). We found no relationship between BMI and positive symptoms in unmedicated CHR patients, the majority of whom had a narrow BMI range between 20 and 30. However, in the smaller sample of CHR patients taking an antidepressant or antipsychotic, BMI was negatively correlated with positive symptoms. Although potentially underpowered, these preliminary findings provide initial steps in elucidating the relationships between metabolic health, neurochemistry, and symptom severity in CHR patients.

Indexed as

Body Mass IndexAdolescentAdultAntidepressive AgentsAntipsychotic AgentsFemaleHumansMalePsychiatric Status Rating ScalesPsychotic DisordersRisk FactorsSeverity of Illness IndexYoung AdultAntidepressive AgentsAntipsychotic Agents

Identifiers

PMID29077651
PMCPMC5678950
OpenAlexW2766569436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.